| Primary |
| Cough |
33.3% |
| Depression |
33.3% |
| Pyrexia |
33.3% |
|
| Anaphylactic Reaction |
20.0% |
| Dizziness |
20.0% |
| Psychomotor Hyperactivity |
20.0% |
| Sinus Disorder |
20.0% |
| Therapeutic Response Unexpected |
20.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
82.1% |
| Chemotherapy |
7.1% |
| Non-small Cell Lung Cancer |
7.1% |
| Wheezing |
3.6% |
|
| Anaphylactic Reaction |
33.3% |
| Lung Infiltration |
22.2% |
| Dehydration |
11.1% |
| Hypoaesthesia |
11.1% |
| Pruritus |
11.1% |
| Urinary Tract Infection |
11.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
14.7% |
| Non-small Cell Lung Cancer |
14.7% |
| Cough |
9.4% |
| Nausea |
8.8% |
| Pain |
8.5% |
| Product Used For Unknown Indication |
7.6% |
| Hypertension |
4.5% |
| Bronchitis |
3.2% |
| Premedication |
3.1% |
| Anxiety |
2.9% |
| Prophylaxis |
2.9% |
| Renal Cell Carcinoma Stage Unspecified |
2.8% |
| Prostate Examination Abnormal |
2.6% |
| Multiple Myeloma |
2.5% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Insomnia |
2.1% |
| Renal Cell Carcinoma |
2.1% |
| Colitis Ulcerative |
1.8% |
| Dermatitis |
1.8% |
| Gastric Cancer Stage Iv |
1.8% |
|
| Vomiting |
7.6% |
| Dyspnoea |
6.5% |
| Pleural Effusion |
6.5% |
| Pneumonitis |
6.5% |
| Weight Decreased |
6.5% |
| Weight Increased |
6.5% |
| Peripheral Coldness |
5.4% |
| Respiratory Failure |
5.4% |
| Sudden Death |
5.4% |
| Thrombocytopenia |
5.4% |
| Haemothorax |
4.3% |
| Paraplegia |
4.3% |
| Pneumonia |
4.3% |
| Rash |
4.3% |
| Sepsis |
4.3% |
| Disease Progression |
3.3% |
| Febrile Neutropenia |
3.3% |
| Gastrointestinal Haemorrhage |
3.3% |
| Hypovolaemia |
3.3% |
| Pneumothorax |
3.3% |
|
